Mirjana Blume — investor profile photo

Mirjana Blume

Senior Financial Executive | International NED | Scale up | Transformation | Decarbonisation | Digitalization

📍 Greater Zurich Area, Switzerland🔄 Updated November 2026💼 5 investments📅 7 years investing🗓 Last invested May 2026
Angel investor🌍 SwitzerlandInvested this year
5
Total investments
0
Early stage
0
Mid stage
0
Late stage
7y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Member of the Board
May 2026
Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 subsidiaries and 60 distributors, the company reaches around 90 markets and employs over 800 people. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas
Experience · 6 entries
All (6)
Investments (5)
Board (5)
2026
Member of the Board
May 2026
Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 subsidiaries and 60 distributors, the company reaches around 90 markets and employs over 800 people. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas
2020
Orell Fuessli Holding AG
Member of the Board
May 2020
Member of the Board & Audit Committee
May 2020
Orell Füssli is a pioneer in the field of security and education. As an expert in security solutions for the state and citizens and as a leading Swiss company in the book retailing sector, Orell Füssli supports its customers with unique and customised services. As a leading systems supplier of security technologies and identification systems and a long-standing partner of states, Orell Füssli sets technological standards. In the fields of security printing and serialisation Orell Füssli offers innovative printing processes, systems and services for the production and successful protection of banknotes, security and identity documents. With its attractive wholesale and specialist bookstores Orell Füssli offers a broad-based shopping experience in all aspects of books. In book retailing Orell Füssli holds a 50% interest in Orell Füssli Thalia AG, which offers a comprehensive range of products in 36 branches in German-speaking Switzerland and various e-commerce services. Orell Füssli provides logistics and other services for libraries and businesses. Orell Füssli was founded over 500 years ago and generates sales of some CHF 250 million with roughly 600 employees at locations in five countries. Orell Füssli is listed on the SIX Swiss Exchange.
Member of the Board
May 2020
Ziel ist es, auf der Basis von ENISO Partners’ disziplinierten und fundamental sowie marktpsychologisch gestützten Verwaltungsmethodik – losgelöst von jeglichen Emotionen – langfristig überdurchschnittliche Resultate für unsere Kunden zu erwirtschaften. Unsere Querdenker forschen und entwickeln seit zwei Jahrzenten mit Enthusiasmus massgeschneiderte Vermögensverwaltungsstrategien durch gezielte Verknüpfung von Informationstechnologie und Finanzmarktwissen für institutionelle und private Investoren: Global Fact Asset Selector GFAS Dieser Baustein dient der dynamischen Steuerung der Vermögensaufteilung des ENISO Systematic Return Mandats und hat zum Ziel, die Schwächephasen an den globalen Aktienmärkten abzufedern. ENISO Risikoappetit-Indikator RAI Anhand einer Vielzahl von verhaltensökonomischen Grössen bestimmt er zielsicher, prognosefrei und risikokontrolliert, ob Anlagerisiken eingegangen oder gemieden werden sollten. Dynamisch steuert er damit die Vermögensaufteilung im ENISO Systematic Risk Mandat und ist gleichzeitig ein Teil des Global Factor Asset Selector GFAS. Global Forces Sector Selector GFSS Sektoren weisen in Abhängigkeit von der Lage am Aktienmarktzyklus unterschiedliche Renditecharakteristiken auf. Durch eine geschickte systematische Rotation zwischen den Sektoren kann eine Mehrrendite erzielt werden. Six Forces Equity Selector SFES Aufgrund ihrer Ausprägung gegenüber verschiedenen fundamentalen und marktpsychologischen Variablen werden die Aktien klassiert. Nur die attraktivsten Aktien werden somit selektiert. Systematic Bond Selector SBS Systematisch wird der Rentenmarkt auf attraktive Anleihen hin untersucht. Zusätzlich werden die einzelnen Obligationen auf ihre Handelbarkeit hin überprüft. Aufgrund dieses systematischen Auswahlprozesses können Sie sich sicher sein, dass ausschliesslich attraktive, gute handelbare und qualitativ einwandfreie Papiere in Ihrem Mandat eingesetzt werden.
2019
EWE Energie und Wasser Erlenbach AG
Member of the Board
May 2019
Show all 6 entries ↓
Investment activity
2019–2026 · 5 investments
201912020320261
Recent (last 2 years)Earlier
Investor lists
Lists that match Mirjana's portfolio